Kolte Dhaval, Abbott Jinnette Dawn, Aronow Herbert D
Division of Cardiovascular Medicine, Brown University, 593 Eddy Street, Providence, RI 02903, USA.
Division of Cardiovascular Medicine, The Warren Alpert Medical School of Brown University, 593 Eddy Street, RIH APC 730, Providence, RI 02903, USA.
Heart Fail Clin. 2017 Jul;13(3):535-570. doi: 10.1016/j.hfc.2017.02.009.
Heart failure (HF) remains the leading cause of hospitalization in older adults and is associated with increased morbidity and mortality despite the use of guideline-directed medical therapy. There has been tremendous progress in the development of novel transcatheter and interventional therapies for HF over the past decade. The evolution of structural heart disease interventions and interventional HF has led to a multidisciplinary heart team approach in the management of HF patients. Careful selection of the appropriate patient population and end points in future randomized controlled trials will be crucial to demonstrate the potential efficacy of the novel interventional HF therapies.
心力衰竭（HF）仍然是老年人住院的主要原因，尽管采用了指南指导的药物治疗，但仍与发病率和死亡率的增加相关。在过去十年中，用于治疗HF的新型经导管和介入治疗方法取得了巨大进展。结构性心脏病干预和介入性HF的发展促使在HF患者管理中采用多学科心脏团队方法。在未来的随机对照试验中，仔细选择合适的患者群体和终点对于证明新型介入性HF治疗的潜在疗效至关重要。
